Last reviewed · How we verify
NCT06690125
Multisensory Integration and Cognitive Awareness in Post-Stroke Unilateral Spatial Neglect
trial testing Classical and computerized assessment in Neglect, Hemispatial in 36 participants. Completed in 2 September 2021.
26 September 2020
Quick facts
| Lead sponsor | Universita di Verona |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 7 November 2018 |
| Primary completion | 26 September 2020 |
| Estimated completion | 2 September 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Classical and computerized assessment
Conditions studied
- Neglect, Hemispatial — all drugs for Neglect, Hemispatial →
- Stroke Acute — all drugs for Stroke Acute →
Sponsor
Universita di Verona — full company profile →
Who can join
Adults 18 to 85, any sex, with Neglect, Hemispatial or Stroke Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of this study is to investigate whether multisensory integration (MSI) mechanisms observed in patients with right hemisphere lesions without neglect remain intact compared to patients with Unilateral Spatial Neglect (USN). This study also allows for a direct comparison between results from paper-based tests and computerized tests, as well as between patients with right hemisphere lesions without neglect and USN patients. The secondary objectives are: To compare these results in order to obtain a more refined definition of USN at both the unisensory level (as computerized tests are rarely used in hospital settings but have proven effective in diagnosing USN) and the multisensory level (since USN is not generally tested in the auditory modality). To measure eye movements in all patients in the study, as this can provide useful information for characterizing patient deficits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06690125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universita di Verona trials
Trials by the same sponsor.
- NCT07393919 — Discontination of Antidepressants in Remitted Depression · Phase 4 · not yet recruiting
- NCT07042724 — Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study · NA · recruiting
- NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
- NCT07119827 — Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury · recruiting
- NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06690125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universita di Verona
- Last refreshed: 15 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06690125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing